Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease
Status:
Unknown status
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This randomized, controlled study aims to evaluate the impact of therapeutic intervention
(step up) for the patients who are clinical remission with Magnetic Resonance
Enterocolonography (MREC) active. In addition, to evaluate the impact of therapeutic step
down for the patients who archived clinical and MREC remission. The primary endpoint is the
rate of clinical remission at 104 weeks.